UB-621

UB-621 · UBP Greater China (Shanghai) Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for UB-621, covering 2022-05-18 to 2022-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 [Phase 2]